Fidelis Animal Health, Inc. Announces Major Label Expansion for Ethiqa XR®
Press Releases
Fidelis Animal Health, Inc.  
November 5, 2024

Fidelis Animal Health, Inc. Announces Major Label Expansion for Ethiqa XR®

Ethiqa XR, an extended-release buprenorphine, adds captive rodents and laboratory rabbits to label for 72-hour control of post-procedural pain.

logo salamanca press

Salamanca Press

Local & Social